Takeda Says FTC's AbbVie Loss Backs Actos Dismissal Bid
Takeda Pharmaceutical Co. Ltd. and several generic-drug makers accused of delaying cheaper versions of diabetes treatment Actos on Tuesday said the recent dismissal of a chunk of one of the Federal...To view the full article, register now.
Already a subscriber? Click here to view full article